Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Neuropsychopharmacology. 2009 Jul 15;34(11):2376–2389. doi: 10.1038/npp.2009.75

Table 2. Sources of variation of neural progenitor cell (nestin-IR) and dividing cells (Ki-67-IR) number in untreated MDD compared to controls and MDD treated with tricyclics (MDD*TCA) or SSRIs (MDD*SSRI) antidepressants.

Nestin-IR cells MDD vs controls MDD vs MDD*TCA MDD vs MDD*SSRI
F1,10 P η2 F1,16 P η2 F1,19 P η2
Factor
Diagnosis 27.268 .014 .901 29.666 .012 .908 8.411 .044 .678
Sex 10.316 .049 .775 15.007 .030 .833 .243 .656 .075
Covariates
Age 1.072 .377 .263 1.066 .378 .262 1.820 .249 .313
PMI 3.587 .155 .545 1.947 .396 .661 26.925 .121 .964
pH 2.529 .210 .457 4.203 .289 .808 1.880 .242 .320
Brain Weight 7.966 .106 .799 6.121 .132 .754 .585 .584 .369
Ki-67-IR cells MDD vs controls MDD vs MDD*TCA MDD vs MDD*SSRI
F1,10 P η2 F1,10 P η2 F1,10 P η2
Factor
Diagnosis 64.476 .077 .985 1489.35 .001 .999 99.201 .064 .990
Sex 19.133 .143 .950 .973 .428 .327 4.774 .272 .828
Covariates
Age .044 .869 .042 8.838 .207 .898 .062 .827 .030
PMI 3.105 .329 .756 3.035 .332 .752 .328 .625 .141
pH 4.568 .279 .820 .917 .514 .478 5.092 .266 .836
Brain Weight .090 .793 .043 .066 .081 .992 3.349 .318 .770

MDD, major depressive disorder; SSRI, selective serotonin reuptake inhibitor; PMI, post-mortem interval. Numbers in bold represent significant results. Numbers in italic represent results with a trend for significance.

HHS Vulnerability Disclosure